Concepedia

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Alie Wurie, Lihua Hou, Qi Liang, Yuhua Li, James B. Russell, Shipo Wu, Jingxin Li, Yuemei Hu, Qiang Guo,

The Lancet · 2016 · 200 citations · 14 references

DOI

Concepts

References

14

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

Ana María Henao-Restrepo, Ira M. Longini, Matthias Egger et al. · The Lancet · 2015 · 796 citations · Full text

, , +15

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 413 citations · Full text

, , +17

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 356 citations · Full text

, , +14

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Daphne A. Stanley, Anna N. Honko, Clement Asiedu et al. · Nature Medicine · 2014 · 352 citations

, , +16

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Iain Milligan, Malick M. Gibani, Richard P. Sewell et al. · JAMA · 2016 · 330 citations

, , +17